Abstract
The use of cell therapy is one of the modern methods of treating various diseases, including cardiovascular diseases. One of the most intensively developing areas of cell transplantation is stem cell therapy. Stem cells are undifferentiated cells that are able to self-renew, forming new stem cells. One of the main questions with the use of stem cells is the weak evidence base that the transplanted cells are able to differentiate into the corresponding tissues, even if the donor cells can be identified in the host tissue in one way or another.
References
- Bersenev A.V. Cell Transplantology – history, current state and prospects. Cell Transplantology and Tissue Engineering. 2005; 1: 49–56 (in Russ.).
- Bockeria L.A., Bockeria O.L., Makarenko V.N., Volkovskaya I.V., Le T.G., Semenova L.D. et al. Сomparative remote results of surgical correction of Ebstein's anomaly with and without the use of autologous stem cells CD 133+ according to magnetic resonance imaging of the heart and daily ECG monitoring using the Holter method. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2021; 22 (1): 47–54 (in Russ.). DOI: 10.24022/1810-0694-2021-22-1-47-54
- Potapov I.V. Cellular cardiomyoplasty with autogenous bone marrow cells: results of three randomized clinical trials. Cell transplantation and tissue engineering. 2007; 1 (2): 22–3 (in Russ.).
- Cahill K.S., Toma C., Pittenger M.F. Кessler P.D., Byrne B.J. Cell therapy in the heart: cell production, transplantation, and applications. Methods Mol. Biol. 2003; 219: 73–81. DOI: 10.1385/1-59259-350-x:73
- Сhachques J.C., Acar C., Herreros J., Cardozo F., Fabian J., Trainini J. et al. Cellular cardiomyoplasty: clinical application. Annals of Thoracic Surgery. 2004; 77 (3): 1121–30. DOI: 10.1016/j.athoracsur.2003.09.081
- Сhachques J.C., Carpenter A. Cellular myoplasty: what are we really trying to achieve? J. Thorac. Cardiovasc. Surg. 2002; 123: 583–4.
- Hassink R.J., Brutel de la Riviere A., Mummery C.L., Doevendans P.A. Transplantation of cells for cardiac repair. J. Am. Coll. Cardiol. 2003; 41 (5): 711–7. DOI: 10.1016/s0735-1097(02)02933-9
- Roell W., Lu Z.J., Bloch W., Siedner S., Tiemann K., Stoecker E. et al. Cellular cardiomyoplasty improves servival after myocardial injury. Circulation. 2002; 21: 2435–41. DOI: 10.1161/01.cir.0000016063.66513.bb
- Golukhova E.Z., Kakuchaya T.T. Cell therapy in cardiology and cardiovascular surgery: a review of randomized trials. Realities and prospects. Creative Cardiology. 2007; 1–2: 55–73 (in Russ.).
- Forrester J.S., Price M.J., Makkar R.R. Review: Current perspective. Stem cell repair of infarcted myocardium an overview for clinicians. Circulation. 2003; 108: 1139–45. DOI: 10.1161/01.cir.0000085305.82019.65
- Buckner C.D., Epstein R.B., Rudolph R.H., Clift R.A., Storb R., Thomas E.D. Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. Blood. 1970; 36 (6): 741. DOI: 10.1182/blood. V35.6.741.741
- Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S. et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen moths follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance St-elevation infract regeneration) trial. Circulation. 2006; 113: 1287–94. DOI: 10.1161/circulationaha.105.575118
- Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C. et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet. 2004; 364: 141–8. DOI: 10.1016/s0140-6736 (04)16626-9
- Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W. et al. Autologous bone marrowderived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized controlled trial. Lancet. 2006; 367: 113–21. DOI: 10.1016/s0140-6736(05)67861-0
- Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T. et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 2006; 355: 1199–209. DOI: 10.1056/nejmoa055706
- Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H. et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 2006; 355: 1210–21. DOI: 10.1056/nejmoa060186
- Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R. et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 2006; 355: 1222–32. DOI: 10.1056/nejmoa051779
- Berishvili I.I., Sigaev I.Yu., Bockeria L.A. Transmyocardial laser revascularization of the myocardium. Bulletin of the Russian Academy of Medical Sciences. 2005; 4: 58–65 (in Russ.).
- Bockeria L.A. Transmyocardial and endomyocardial laser revascularization is a new method of surgical treatment of coronary heart disease. Annals of Surgery. 1997; 6: 17–22 (in Russ.).
- Bockeria L.A., Berishvili I.I. Transmyocardial laser revascularization (TMLR) in combination with recombinant BFGF in patients with coronary heart disease. The Bulletin of the Bakoulev Center. Cardiovascular Diseases. 2004; 5 (11): 80 (in Russ.).
- Bockeria L.A., Berishvili I.I., Vasiltsov V.V., Zelenov E.V., Egorov E.N., Panchenco V.Ya. et al. Transmyocardial laser revascularization: intelligent laser CO2 systems, preoperative diagnostics and clinical results. Anniversary scientific and technical conference “Lasers in science, technology, medicine”. Moscow; 2004 (in Russ.).
- Bockeria L.A., Berishvili I.I., Ignatieva Yu.V., Vakhromeeva M.N. Transmyocardial laser revascularization in combination with coronary artery bypass grafting in the treatment of patients with coronary artery disease with diffuse coronary artery disease. Cardiovascular Surgery. 2015; 3: 3–9 (in Russ.).
- Bockeria L.A., Berishvili I.I., Sigaev I.Yu. Alternative methods of myocardial revascularization. Bulletin of the Russian Academy of Medical Sciences. 2009; 12: 46–51 (in Russ.).
- Bockeria L.A., Berishvili I.I., Sigaev I.Yu., Khelimsky A.A. Transmyocardial laser revascularization of the myocardium in the treatment of coronary heart disease. In: The main problems of surgical treatment of coronary heart disease. Joint scientific session of the Bakoulev Scientific Center of Cardiovascular Surgery of the Russian Academy of Medical Sciences and the Voronezh Regional Clinical Hospital. Moscow; 1999: 14 (in Russ.).
- Bockeria L.A., Bockeria O.L., Petrosyan A.D., Sсhwartz V.A., Donakanyan S.A., Biniashvilli M.B. Immediate results of the operation of isolated transmyocardial laser revascularization in combination with intramyocardial injection of autologous bone marrow stem cells. The Bulletin of Bakoulev Center. Cardiovascular Surgery. 2016; 17 (6): 42–52 (in Russ.).
- Bockeria L.A., Donakanyan S.A. The possibilities of using stem cells in the treatment of coronary heart disease. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2014; 15 (6): 29–39 (in Russ.).
- Bockeria L.A., Donakanyan S.A. Modern approaches to the surgical treatment of multivessel lesions of the coronary bed. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2013; 14 (6): 20–9 (in Russ.).
- Bockeria L.A., Petrosyan A.D. Transmyocardial laser revascularization in combination with intramyocardial injection of autologous bone marrow stem cells. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2017; 18 (4): 368–79 (in Russ.). DOI: 10.24022/1810-0694-2017-18-4-368-379
About the authors
- Leo A. Bockeria, Academic RAS and RAMS, President; ORCID
- Lyudmila D. Semenova, Cardiologist; ORCID
